Cargando…

Inhibition of abnormal C/EBPβ/α‐Syn signaling pathway through activation of Nrf2 ameliorates Parkinson's disease‐like pathology

Parkinson's disease (PD) is characterized by the formation of Lewy bodies (LBs) in the brain. These LBs are primarily composed of α‐Synuclein (α‐Syn), which has aggregated. A recent report proposes that CCAAT/enhancer‐binding proteins β (C/EBPβ) may act as an age‐dependent transcription factor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Zefang, Huang, Lixuan, Cao, Qianqian, Luo, Hanyue, Yao, Wei, Zhang, Ji‐chun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10577548/ https://www.ncbi.nlm.nih.gov/pubmed/37614147 http://dx.doi.org/10.1111/acel.13958

Ejemplares similares

Suppression of abnormal α-synuclein expression by activation of BDNF transcription ameliorates Parkinson’s disease-like pathology
por: Cao, Qianqian, et al.
Publicado: (2022)

Nrf2 regulates the arginase 1(+) microglia phenotype through the initiation of TREM2 transcription, ameliorating depression-like behavior in mice
por: He, Lujuan, et al.
Publicado: (2022)

Noncanonical Roles of hα-syn (A53T) in the Pathogenesis of Parkinson's Disease: Synaptic Pathology and Neuronal Aging
por: Wang, Qing-Jun, et al.
Publicado: (2020)

Distinct Aβ pathology in the olfactory bulb and olfactory deficits in a mouse model of Aβ and α‐syn co‐pathology
por: Friesen, Marina, et al.
Publicado: (2021)

Toll-like Receptor 4 Is Upregulated in Parkinson’s Disease Patients and Co-Localizes with pSer129αSyn: A Possible Link with the Pathology
por: Conte, Carmela, et al.
Publicado: (2023)

A Combined α-Synuclein/Fibril (SynFib) Model of Parkinson-Like Synucleinopathy Targeting the Nigrostriatal Dopamine System
por: Björklund, Anders, et al.
Publicado: (2022)

Injection of α-syn-98 Aggregates Into the Brain Triggers α-Synuclein Pathology and an Inflammatory Response
por: Du, Tingfu, et al.
Publicado: (2019)

Amelioration of pathologic α-synuclein-induced Parkinson’s disease by irisin
por: Kam, Tae-In, et al.
Publicado: (2022)

C/EBPβ/AEP is age-dependently activated in Parkinson’s disease and mediates α-synuclein in the gut and brain
por: Wang, Hualong, et al.
Publicado: (2023)

C/EBPα Expression is Partially Regulated by C/EBPβ in Response to DNA Damage and C/EBPα Deficient Fibroblasts Display an Impaired G(1) Checkpoint
por: Ranjan, Rakesh, et al.
Publicado: (2009)

Activation of MT2 receptor ameliorates dendritic abnormalities in Alzheimer’s disease via C/EBPα/miR‐125b pathway
por: Tang, Hui, et al.
Publicado: (2019)

LRRK2 modifies α-syn pathology and spread in mouse models and human neurons
por: Bieri, Gregor, et al.
Publicado: (2019)

C/EBPα and C/EBPβ Are Required for Sebocyte Differentiation and Stratified Squamous Differentiation in Adult Mouse Skin
por: House, John S., et al.
Publicado: (2010)

Comparative Analysis of Total Alpha-Synuclein (αSYN) Immunoassays Reveals That They Do Not Capture the Diversity of Modified αSYN Proteoforms
por: Petricca, Lara, et al.
Publicado: (2022)

α-Synuclein pathology in Parkinson disease activates homeostatic NRF2 anti-oxidant response
por: Delaidelli, Alberto, et al.
Publicado: (2021)

The C/EBPβ LIP isoform rescues loss of C/EBPβ function in the mouse
por: Bégay, Valérie, et al.
Publicado: (2018)

Baicalin Represses C/EBPβ via Its Antioxidative Effect in Parkinson's Disease
por: Lei, Kecheng, et al.
Publicado: (2020)

Chaperone proteins as ameliorators of α-synuclein-induced synaptic pathologies: insights into Parkinson’s disease
por: Banks, Susan M.L., et al.
Publicado: (2020)

The AML-associated K313 mutation enhances C/EBPα activity by leading to C/EBPα overexpression
por: Gentle, Ian Edward, et al.
Publicado: (2021)

Reduction of αSYN Pathology in a Mouse Model of PD Using a Brain-Penetrating Bispecific Antibody
por: Roshanbin, Sahar, et al.
Publicado: (2022)

IFNα and β Mediated JCPyV Suppression through C/EBPβ-LIP Isoform
por: May, Dana, et al.
Publicado: (2021)

SIGIRR deficiency contributes to CD4 T cell abnormalities by facilitating the IL1/C/EBPβ/TNF-α signaling axis in rheumatoid arthritis
por: Teng, Xiu, et al.
Publicado: (2022)

Characterizing the Retinal Phenotype of the Thy1-h[A30P]α-syn Mouse Model of Parkinson’s Disease
por: Veys, Lien, et al.
Publicado: (2021)

Application of α-Syn Real-Time Quaking-Induced Conversion for Brain and Skin Specimens of the Chinese Patients With Parkinson’s Disease
por: Chen, Dong-Dong, et al.
Publicado: (2022)

Seasons of Syn
por: Hunter‐Cevera, Kristen R., et al.
Publicado: (2019)

Lewy Body-Associated Proteins A-Synuclein (a-syn) as a Plasma-Based Biomarker for Parkinson’s Disease
por: Zhao, Xuemiao, et al.
Publicado: (2022)

C/EBPβ Regulates TFAM Expression, Mitochondrial Function and Autophagy in Cellular Models of Parkinson’s Disease
por: Sierra-Magro, Ana, et al.
Publicado: (2023)

The Histone Demethylase PHF2 Promotes Fat Cell Differentiation as an Epigenetic Activator of Both C/EBPα and C/EBPδ
por: Lee, Kyoung-Hwa, et al.
Publicado: (2014)

Detection and Mitigation of SYN Flooding Attacks through SYN/ACK Packets and Black/White Lists
por: Yang, Chun-Hao, et al.
Publicado: (2023)

Shwachman–Bodian–Diamond syndrome (SBDS) protein deficiency impairs translation re-initiation from C/EBPα and C/EBPβ mRNAs
por: In, Kyungmin, et al.
Publicado: (2016)

Protective Effect of Compound Formula Rehmannia against Neurotoxicity and Apoptosis Induced by α-Syn in In Vivo and In Vitro Models of Parkinson's Disease
por: Teng, Long, et al.
Publicado: (2020)

Gut dysbiosis contributes to amyloid pathology, associated with C/EBPβ/AEP signaling activation in Alzheimer’s disease mouse model
por: Chen, Chun, et al.
Publicado: (2020)

C/EBPα: critical at the origin of leukemic transformation
por: Roe, Jae-Seok, et al.
Publicado: (2014)

TGF-β-induced α-SMA expression is mediated by C/EBPβ acetylation in human alveolar epithelial cells
por: Ding, Hui, et al.
Publicado: (2021)

Role of α- and β-Synucleins in the Axonal Pathology of Parkinson’s Disease and Related Synucleinopathies
por: Sekigawa, Akio, et al.
Publicado: (2015)

TonEBP Suppresses the HO-1 Gene by Blocking Recruitment of Nrf2 to Its Promoter
por: Yoo, Eun Jin, et al.
Publicado: (2019)

[(18)F]FDG PET/CT Studies in Transgenic Hualpha-Syn (A53T) Parkinson’s Disease Mouse Model of α-Synucleinopathy
por: Mondal, Rommani, et al.
Publicado: (2021)

Turn-Directed α-β Conformational Transition of α-syn12 Peptide at Different pH Revealed by Unbiased Molecular Dynamics Simulations
por: Liu, Lei, et al.
Publicado: (2013)

HIPK1 Inhibition Protects against Pathological Cardiac Hypertrophy by Inhibiting the CREB‐C/EBPβ Axis
por: Bei, Yihua, et al.
Publicado: (2023)

Emerging functions of C/EBPβ in breast cancer
por: Matherne, Megan G., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8mf27cu6r3pkvaet7vn5chbmr5